Hormone Replacement Therapy Timing Linked to Lower LATE-NC Risk
[SUBJECT]
Personalized briefing
Discovery of the day · Neurology
Hormone replacement therapy and its association with LATE‐NC in older adults
Dear Damien Boorman, this is your personalized scientific intelligence briefing — curated for your work in Neurology.
Key finding
Medicine · Neurology · Dementia Neuropathology
Discovery of the day
This study demonstrates that hormone replacement therapy (HRT) initiated within five years before or after menopause (OR = 0.70, p = 0.03) or used for 8–16 years (OR = 0.44, p = 0.006) is significantly associated with reduced odds of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC), a common dementia mimic. The finding, derived from 2,056 participants in the Religious Orders Study and Memory and Aging Project, was specific to female participants with available neuropathology data. For your research on preclinical models of pain and consciousness, this work underscores the importance of timing and duration in potential neuroprotective interventions and provides a compelling framework for investigating how hormonal modulation may alter neurodegenerative trajectories at the mechanistic level.
Novelty
82%
Rigor
91%
Significance
78%
Validity
88%
Clarity
94%
Advertisement
GroupRFQ — join group deals on lab & medical equipment. Pool orders, unlock volume pricing. See open deals →
Your briefing is personalized based on your selected fields, keywords, and research interests.
